Combination of systemic immune-inflammation index and albumin-bilirubin score predict prognosis of sequential therapy with sorafenib and regorafenib in unresectable hepatocellular carcinoma

Tai-An Cheng; Wei Teng; Po-Ting Lin; Chen-Chun Lin; Chun-Yen Lin; Shi-Ming Lin

Combination of systemic immune-inflammation index and albumin-bilirubin score predict prognosis of sequential therapy with sorafenib and regorafenib in unresectable hepatocellular carcinoma

Tai-An Cheng, Wei Teng, Po-Ting Lin, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

醫學系

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
期刊	Journal of Hepatology
卷	77
出版狀態	已出版 - 2022

引用此

@article{4fc8b44d63f14e67b1460608491e488f,

title = "Combination of systemic immune-inflammation index and albumin-bilirubin score predict prognosis of sequential therapy with sorafenib and regorafenib in unresectable hepatocellular carcinoma",

author = "Tai-An Cheng and Wei Teng and Po-Ting Lin and Chen-Chun Lin and Chun-Yen Lin and Shi-Ming Lin",

year = "2022",

language = "American English",

volume = "77",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Combination of systemic immune-inflammation index and albumin-bilirubin score predict prognosis of sequential therapy with sorafenib and regorafenib in unresectable hepatocellular carcinoma

AU - Cheng, Tai-An

AU - Teng, Wei

AU - Lin, Po-Ting

AU - Lin, Chen-Chun

AU - Lin, Chun-Yen

AU - Lin, Shi-Ming

PY - 2022

Y1 - 2022

M3 - Journal Article

SN - 0168-8278

VL - 77

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -